...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith AGM
6
Dec 20, 2016 09:32AM

Nextblockbuster,

Thanks for re-posting and sharing your comments, and thank you to F6 over on Investor Village for your post.

BearDownAZ

Share
New Message
Please login to post a reply